Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
Journal of Interventional Medicine
|
May 14, 2023
Management of traumatic peripheral artery pseudoaneurysm: A 10-year experience at a single center
Yingliang Wang, Hai Zheng, Wei Yao, et al.
Cell Death Discovery
|
October 6, 2022
A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy
Dongyuan Wang, Jiacheng Liu, Tongqiang Li, et al.
BMC Cancer
|
March 29, 2022
Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination
Shuguang Ju, Chen Zhou, Junwen Hu, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
|
July 17, 2023
Mild Prolongation of Prothrombin Time Does Not Affect the Safety and Prognosis of Transjugular Intrahepatic Portal Shunt: Based on Real-World Data
Yaowei Bai, Jiacheng Liu, Yang Chen, et al.
Quantitative Imaging in Medicine and Surgery
|
May 14, 2023
Changes and influencing factors of liver volume after transjugular intrahepatic portosystemic shunt: a retrospective cohort study
Yaowei Bai, Jiacheng Liu, Jianbo Zhao, et al.
Biomaterials
|
January 25, 2024
Hypoxia-activated cascade nanovaccine for synergistic chemoembolization-immune therapy of hepatocellular carcinoma
Qin Shi, Wen Zhang, Yongjie Zhou, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
Journal of Interventional Medicine
|
May 14, 2023
Management of traumatic peripheral artery pseudoaneurysm: A 10-year experience at a single center
Yingliang Wang, Hai Zheng, Wei Yao, et al.
Cell Death Discovery
|
October 6, 2022
A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy
Dongyuan Wang, Jiacheng Liu, Tongqiang Li, et al.
BMC Cancer
|
March 29, 2022
Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination
Shuguang Ju, Chen Zhou, Junwen Hu, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
|
July 17, 2023
Mild Prolongation of Prothrombin Time Does Not Affect the Safety and Prognosis of Transjugular Intrahepatic Portal Shunt: Based on Real-World Data
Yaowei Bai, Jiacheng Liu, Yang Chen, et al.
Quantitative Imaging in Medicine and Surgery
|
May 14, 2023
Changes and influencing factors of liver volume after transjugular intrahepatic portosystemic shunt: a retrospective cohort study
Yaowei Bai, Jiacheng Liu, Jianbo Zhao, et al.
Biomaterials
|
January 25, 2024
Hypoxia-activated cascade nanovaccine for synergistic chemoembolization-immune therapy of hepatocellular carcinoma
Qin Shi, Wen Zhang, Yongjie Zhou, et al.
Page
of 5